Acumen pharmaceuticals reports financial results for second quarter 2021 and business highlights

Charlottesville, va. and carmel, ind., aug. 16, 2021 (globe newswire) -- acumen pharmaceuticals, inc. (nasdaq: abos) (acumen), a clinical stage biopharmaceutical company focused on the development of novel targeted therapeutics for alzheimer's disease (ad), today reported financial results for the quarter ended june 30, 2021 and provided recent business highlights.
ABOS Ratings Summary
ABOS Quant Ranking